Evidence map›Paper›PMID 41797210›Full record

ReviewJournal of neurochemistry2026

Astrocyte Bioenergetic Remodeling as a Central Trait of Disrupted Glucocorticoid Signaling: Mechanisms and Implications for Stress Vulnerability.

Paweł Hanus, Dorota Frydecka, Michał Ślęzak

Erratum issuedAbstract readReview
In one paragraph

Review in Journal of neurochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Paweł HanusDepartment of Psychiatry, Medical University of Wroclaw, Wroclaw, Poland.ORCID https://orcid.org/0000-0001-7337-3199
Dorota FrydeckaDepartment of Psychiatry, Medical University of Wroclaw, Wroclaw, Poland.
Michał ŚlęzakP4Health, Łukasiewicz Research Network-PORT Polish Center for Technology Development, Wroclaw, Poland.

Funding

Ministerstwo Edukacji i Nauki DWD/6/0506/2022Narodowe Centrum Nauki 2023/05/Y/NZ4/00124/WEAVE-UNISONO
6 · The paper itself

Abstract

Glucocorticoids (GCs) are central to the organism's adaptation to stress, coordinating systemic energy distribution and neuroendocrine signaling. While acute effects of GCs are adaptive, chronic GC exposure is increasingly recognized as an important factor contributing to the pathophysiology of neuropsychiatric disorders, such as post-traumatic stress disorder (PTSD) or major depressive disorder (MDD). A piling evidence points to astrocytes as a central integrator of brain response to stress hormones, including GCs. In this review, we discuss a biphasic regulation of astrocyte metabolism by GCs. According to the hypothesis, astrocytes undergo metabolic adaptations in response to GC: acute exposure leads to the enhancement of astrocyte metabolism through upregulation of glycolysis, mitochondrial activation, and glutamate clearance. In turn, prolonged GC exposure induces a metabolic shift toward branched-chain amino acid and lipid catabolism, promoting mitochondrial reactive oxygen species (ROS) production and impairing key homeostatic functions, including the astrocyte-neuron lactate shuttle and calcium signaling. Progressive disruption of astrocytes' supporting function may subsequently lead to synaptic dysregulation and energy imbalance in stress-related brain pathology. We postulate that a detailed understanding of this dynamic regulation is necessary for targeting astrocyte-specific metabolic mechanisms in neuropsychiatric disorders.

Indexed as

AstrocytesEnergy MetabolismGlucocorticoidsSignal TransductionStress, PsychologicalAnimalsHumansMetabolic ReprogrammingMitochondriaGlucocorticoidsastrocyte metabolismbrain energy metabolismglucocorticoid signalingneuroenergetics

Identifiers

PMID41797210
PMCPMC12968365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.